Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "Talk:Oroboros Diagnostics"

From Bioblast
Line 7: Line 7:


== Oroboros Diagnostics ==
== Oroboros Diagnostics ==
::::* COMET - eCall - Project No. 47281252
::::* COMET Center (K1) - eCall - Project No. 47281252
::::* '''Duration''': 18-24 months
::::* '''Duration''': 18-24 months
::::* '''Start''': tbc
::::* '''Start''': tbc
Line 45: Line 45:


== Oroboros project involvement ==
== Oroboros project involvement ==
::::* Oroboros Instruments is a project partner in the COMET project with ACMIT GmbH.
::::* Oroboros Instruments is a partner in the network of ACMIT GmbH - Austria Center for Medical Innovation and Technology.
::::* ACMIT is a COMET Center (K1) funded within COMET – Competence Centers for Excellent Technologies – by BMK, BMDW as well as the co-financing federal provinces Lower Austria and Tyrol. The COMET programme is managed by FFG (www.ffg.at/comet).


== Oroboros Diagnostics Events ==
== Oroboros Diagnostics Events ==

Revision as of 08:11, 19 October 2022

                



Talk:Oroboros Diagnostics

Oroboros Diagnostics - instrumental innovation to diagnostic standard

FFG

Oroboros Diagnostics

  • COMET Center (K1) - eCall - Project No. 47281252
  • Duration: 18-24 months
  • Start: tbc


About Oroboros Diagnostics

  • Oroboros Diagnostics will be established as a new branch (GmbH) with a business plan to launch an 8-chamber medical device (O8k) for mitochondrial diagnostics. The O8k as a medical device is required for clinical use, with simplifications (O2 measurement only) and specific optimizations (e.g. optical sensor) compared to the general research instrument O2k. A medical device requires an organizational platform separate from the research-linked model of Oroboros Instruments.


Aims

  • Instrumental development and market launch of O8k as a research device for applications by early testers.
  • Formulation and creation of basic documents to start an ISO 13485-compliant product development for medical device. Formulation of a project plan including milestone plan and budget calculation up to CE approval.
  • Instrumental development of O8k as a medical device for broader application of mitochondrial diagnostics. Potential development of titration robotics.


References

Coordinator

Network

Participants

ACMIT GmbH Austrian Center for Medical Innovation and Technology - www.acmit.at
  • DI Bernhard Nußbaumer, MAS, EMBA - Chief Business Development Officer
Oroboros Instruments GmbH - www.oroboros.at


Oroboros project involvement

  • Oroboros Instruments is a partner in the network of ACMIT GmbH - Austria Center for Medical Innovation and Technology.
  • ACMIT is a COMET Center (K1) funded within COMET – Competence Centers for Excellent Technologies – by BMK, BMDW as well as the co-financing federal provinces Lower Austria and Tyrol. The COMET programme is managed by FFG (www.ffg.at/comet).

Oroboros Diagnostics Events

Oroboros Diagnostics Publications

Links

News and articles


Support

This project has received funding from the Austrian Research Promotion Funding Agency (FFG).
FFG-logo.png